200 related articles for article (PubMed ID: 32005861)
1. The iron chelator Deferasirox causes severe mitochondrial swelling without depolarization due to a specific effect on inner membrane permeability.
Gottwald EM; Schuh CD; Drücker P; Haenni D; Pearson A; Ghazi S; Bugarski M; Polesel M; Duss M; Landau EM; Kaech A; Ziegler U; Lundby AKM; Lundby C; Dittrich PS; Hall AM
Sci Rep; 2020 Jan; 10(1):1577. PubMed ID: 32005861
[TBL] [Abstract][Full Text] [Related]
2. Deferasirox-Dependent Iron Chelation Enhances Mitochondrial Dysfunction and Restores p53 Signaling by Stabilization of p53 Family Members in Leukemic Cells.
Calabrese C; Panuzzo C; Stanga S; Andreani G; Ravera S; Maglione A; Pironi L; Petiti J; Shahzad Ali MS; Scaravaglio P; Napoli F; Fava C; De Gobbi M; Frassoni F; Saglio G; Bracco E; Pergolizzi B; Cilloni D
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081324
[TBL] [Abstract][Full Text] [Related]
3. Indium (III) induces isolated mitochondrial permeability transition by inhibiting proton influx and triggering oxidative stress.
Yuan L; Zhang J; Liu Y; Zhao J; Jiang F; Liu Y
J Inorg Biochem; 2017 Dec; 177():17-26. PubMed ID: 28918354
[TBL] [Abstract][Full Text] [Related]
4. Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox.
Amano S; Kaino S; Shinoda S; Harima H; Matsumoto T; Fujisawa K; Takami T; Yamamoto N; Yamasaki T; Sakaida I
BMC Cancer; 2020 Jul; 20(1):681. PubMed ID: 32698792
[TBL] [Abstract][Full Text] [Related]
5. Deferasirox drives ROS-mediated differentiation and induces interferon-stimulated gene expression in human healthy haematopoietic stem/progenitor cells and in leukemia cells.
Tataranni T; Mazzoccoli C; Agriesti F; De Luca L; Laurenzana I; Simeon V; Ruggieri V; Pacelli C; Della Sala G; Musto P; Capitanio N; Piccoli C
Stem Cell Res Ther; 2019 Jun; 10(1):171. PubMed ID: 31196186
[TBL] [Abstract][Full Text] [Related]
6. Comparison of various iron chelators and prochelators as protective agents against cardiomyocyte oxidative injury.
Jansová H; Macháček M; Wang Q; Hašková P; Jirkovská A; Potůčková E; Kielar F; Franz KJ; Simůnek T
Free Radic Biol Med; 2014 Sep; 74():210-21. PubMed ID: 24992833
[TBL] [Abstract][Full Text] [Related]
7. Biochemical effects of deferasirox and deferasirox-loaded nanomicellesin iron-intoxicated rats.
Rahdar A; Hajinezhad MR; Sargazi S; Bilal M; Barani M; Karimi P; Kyzas GZ
Life Sci; 2021 Apr; 270():119146. PubMed ID: 33545199
[TBL] [Abstract][Full Text] [Related]
8. Changes in specific lipids regulate BAX-induced mitochondrial permeability transition.
Martínez-Abundis E; García N; Correa F; Franco M; Zazueta C
FEBS J; 2007 Dec; 274(24):6500-10. PubMed ID: 18028444
[TBL] [Abstract][Full Text] [Related]
9. The iron chelator deferasirox synergises with chemotherapy to treat triple-negative breast cancers.
Tury S; Assayag F; Bonin F; Chateau-Joubert S; Servely JL; Vacher S; Becette V; Caly M; Rapinat A; Gentien D; de la Grange P; Schnitzler A; Lallemand F; Marangoni E; Bièche I; Callens C
J Pathol; 2018 Sep; 246(1):103-114. PubMed ID: 29876931
[TBL] [Abstract][Full Text] [Related]
10. Reversible and irreversible mitochondrial swelling in vitro.
Khmelinskii I; Makarov V
Biophys Chem; 2021 Nov; 278():106668. PubMed ID: 34418677
[TBL] [Abstract][Full Text] [Related]
11. In silico simulation of reversible and irreversible swelling of mitochondria: The role of membrane rigidity.
Makarov VI; Khmelinskii I; Khuchua Z; Javadov S
Mitochondrion; 2020 Jan; 50():71-81. PubMed ID: 31669621
[TBL] [Abstract][Full Text] [Related]
12. Novel neuroprotective compound SCH-20148 rescues thymocytes and SH-SY5Y cells from thapsigargin-induced mitochondrial membrane potential reduction and cell death.
Muramatsu Y; Maemoto T; Iwashita A; Matsuoka N
Eur J Pharmacol; 2007 Jun; 563(1-3):40-8. PubMed ID: 17343843
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial calcium uniporter blocker effectively prevents brain mitochondrial dysfunction caused by iron overload.
Sripetchwandee J; Sanit J; Chattipakorn N; Chattipakorn SC
Life Sci; 2013 Mar; 92(4-5):298-304. PubMed ID: 23333832
[TBL] [Abstract][Full Text] [Related]
14. Taurine prevents mitochondrial membrane permeabilization and swelling upon interaction with manganese: Implication in the treatment of cirrhosis-associated central nervous system complications.
Ahmadi N; Ghanbarinejad V; Ommati MM; Jamshidzadeh A; Heidari R
J Biochem Mol Toxicol; 2018 Nov; 32(11):e22216. PubMed ID: 30152904
[TBL] [Abstract][Full Text] [Related]
15. Computational Modeling of In Vitro Swelling of Mitochondria: A Biophysical Approach.
Makarov VI; Khmelinskii I; Javadov S
Molecules; 2018 Mar; 23(4):. PubMed ID: 29597314
[TBL] [Abstract][Full Text] [Related]
16. Polyhydroxybutyrate targets mammalian mitochondria and increases permeability of plasmalemmal and mitochondrial membranes.
Elustondo PA; Angelova PR; Kawalec M; Michalak M; Kurcok P; Abramov AY; Pavlov EV
PLoS One; 2013; 8(9):e75812. PubMed ID: 24086638
[TBL] [Abstract][Full Text] [Related]
17. Ferutinin Induces Membrane Depolarization, Permeability Transition Pore Formation, and Respiration Uncoupling in Isolated Rat Liver Mitochondria by Stimulation of Ca
Ilyich T; Charishnikova O; Sekowski S; Zamaraeva M; Cheshchevik V; Dremza I; Cheshchevik N; Kiryukhina L; Lapshina E; Zavodnik I
J Membr Biol; 2018 Aug; 251(4):563-572. PubMed ID: 29594529
[TBL] [Abstract][Full Text] [Related]
18. On the effects of paraquat on isolated mitochondria. Evidence that paraquat causes opening of the cyclosporin A-sensitive permeability transition pore synergistically with nitric oxide.
Costantini P; Petronilli V; Colonna R; Bernardi P
Toxicology; 1995 May; 99(1-2):77-88. PubMed ID: 7539163
[TBL] [Abstract][Full Text] [Related]
19. Synergistic intracellular iron chelation combinations: mechanisms and conditions for optimizing iron mobilization.
Vlachodimitropoulou Koumoutsea E; Garbowski M; Porter J
Br J Haematol; 2015 Sep; 170(6):874-83. PubMed ID: 26033030
[TBL] [Abstract][Full Text] [Related]
20. Iron Chelator Deferasirox Reduces
Puri S; Kumar R; Rojas IG; Salvatori O; Edgerton M
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30718249
[No Abstract] [Full Text] [Related]
[Next] [New Search]
